Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ReHand. The First Tablet Solution for the Neurological Post-Stroke Rehabilitation of the Most Functional Body Segment, The Hand

NCT05204225 is registered in ClinicalTrials.gov with University of Seville as lead sponsor.

NCT NCT05204225
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05204225 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ReHand. The First Tablet Solution for the Neurological Post-Stroke Rehabilitation of the Most Functional Body Segment, The Hand
Lead sponsor
University of Seville
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2022
Completion date
March 26, 2022
Enrollment
33 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

hand presentation, mobility limitation, motor disorders, neurologic disorder, stroke